Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[β-C]DOPA

Nuclear Medicine Communications

Volumn 27, Issue 9, 2006, Pages 723-731

  Ito, Hiroshi ^a   Ota, Miho ^a   Ikoma, Yoko ^b   Seki, Chie ^b   Yasuno, Fumihiko ^a   Takano, Akihiro ^a   Maeda, Jun ^a   Nakao, Ryuji ^c   Suzuki, Kazutoshi ^c   Suhara, Tetsuya ^a  

^a National Institute of Radiological Sciences   (Japan)

^b National Institute of Radiological Sciences   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Brain; DOPA; Dopamine; PET

Indexed keywords

AMINO ACID; LEVODOPA; LEVODOPA C 11; UNCLASSIFIED DRUG;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; DEGENERATIVE DISEASE; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; QUANTITATIVE ANALYSIS;

ADULT; BLOOD-BRAIN BARRIER; BRAIN; CARBON RADIOISOTOPES; DOPAMINE; HUMANS; KINETICS; LEVODOPA; MALE; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 33747032262     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000230069.08576.6d     Document Type: Article

References (52)

1. Gjedde A. Exchange diffusion of large neutral amino acids between blood and brain. In: Rakic L, Begley DJ, Davson H, Zlokovic BV (editors): Peptide and Amino Acid Transport Mechanisms in the Cerebral Nervous System. New York: Stockton Press; 1988, pp. 209-217.
2. Gjedde A, Reith J, Dyve S, Leger G, Guttman M, Diksic M, et al. Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci USA 1991; 88:2721-2725.
3. 18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab 1991; 11:898-913.
4. 11C]dopa in humans studied by positron emission tomography. J Neural Transm Gen Sect 1991; 86:25-41.
5. 11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography. Acta Neurol Scand 1992; 85:166-173.
6. Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998; 29:37-61.
7. Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci USA 1994; 91:11651-11654.
8. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346:1130-1131.
9. Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 1998; 42:211-221.
10. 11C) DOPA and PET. Biol Psychiatry 1999; 46:681-688.
11. Dao-Castellana MH, Paillere-Martinot ML, Hantraye P, Attar-Levy D, Remy P, Crouzel C, et al. Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res 1997; 23:167-174.
12. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5:584-590.
13. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38:1614-1623.
14. Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans JL (editors): Three-dimensional Image Reconstruction in Radiology and Nuclear Medicine. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1996, pp. 255-268.
15. 11C-labelled L-tyrosine and L-DOPA. Acta Chem Scand 1990; 44:183-188.
16. 11C]amino acids using an immobilized enzyme column. Appl Radiat Isot 2000; 52:199-204.
17. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B. Automatic blood sampling systems for positron emission tomography. IEEE Trans Nucl Sci 1988; 35:703-707.
18. Suzuki K, Takei M, Kida T. Development of an analyzing system for the sensitive measurement of radioactive metabolites on the PET study. J Labelled Cpd Radiopharm 1999; 42:S658-S660.
19. Takei M, Kida T, Suzuki K. Sensitive measurement of positron emitters eluted from HPLC. Appl Radiat Isot 2001; 55:229-234.
20. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990; 10:458-466.
21. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371-388.
22. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res 1982; 257:237-274.
23. Marquardt D. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 1963; 11:431-441.
24. Brown RM, Crane AM, Goldman PS. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res 1979; 168:133-150.
25. Lloyd KG, Hornykiewicz O. Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem 1972; 19:1549-1559.
26. Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 1971; 221:1629-1639.
27. +-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS. Neuroscience 2001; 104:1-14.
28. 18F]-fluorophenylalanine and PET. J Nucl Med 1995; 36:1232-1237.
29. Smith QR, Momma S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 1987; 49:1651-1658.
30. Gomes P, Soares-da-Silva P. L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4. Brain Res 1999; 829:143-150.
31. 18F-DOPA PET study. Brain Res 2003; 982:137-145.
32. 125I]PE2I. Neuroimage 1999; 9:108-116.
33. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 1994; 11:245-256.
34. 125I]epidepride. Synapse 1996; 23:115-123.
35. 11C]raclopride: PET with anatomic standardization technique. Neuroimage 1999; 9:235-242.
36. 11C]FLB 457. Neuroimage 1999; 10:666-674.
37. Garnett ES, Firnau G, Nahmias C, Sood S, Belbeck L. Blood-brain barrier transport and cerebral utilization of dopa in living monkeys. Am J Physiol 1980; 238:R318-R327.
38. 18F]fluoro-L-dopa in human blood. J Nucl Med 1988; 29:363-369.
39. 3H]L-dopa in rats. Biochem Pharmacol 1990; 39:1853-1860.
40. 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system. J Cereb Blood Flow Metab 1999; 19:1142-1149.
41. 18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J Cereb Blood Flow Metab 1994; 14:664-670.
42. Dhawan V, Ishikawa T, Patlak C, Chaly T, Robeson W, Belakhlef A, et al. Combined FDOPA and 3OMFD PET studies in Parkinson's disease. J Nucl Med 1996; 37:209-216.
43. 11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography. J Neural Transm Gen Sect 1992; 87:15-22.
44. 18F]fluorodopamine storage capacity. J Cereb Blood Flow Metab 2005; 25:807-819.
45. 11C]dopa. Brain Res 1992; 578:122-128.
46. 11C]DOPA and its metabolites for the validation of positron emission tomography studies. J Pharm Biomed Anal 1995; 13:361-367.
47. 11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J Cereb Blood Flow Metab 1990; 10:727-739.
48. Pardridge WM. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 1977; 28:103-108.
49. 18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol 1986; 20:258-262.
50. Stout DB, Huang SC, Melega WP, Raleigh MJ, Phelps ME, Barrio JR. Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics. J Cereb Blood Flow Metab 1998; 18:43-51.
51. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197:1205-1210.
52. Crone C. The permeability of capillaries in various organs as determined by use of the ‘indicator diffusion’ method. Acta Physiol Scand 1963; 58:292-305.